(Q45165898)

10 December 2017

title

Hepatitis B vaccination for staff in institutions for the mentally handicapped (English)

1 reference

10 December 2017

0 references

Jayaratnam R

1

1 reference

10 December 2017

publication date

1 May 1988

1 reference

10 December 2017

1 reference

10 December 2017

volume

102

1 reference

10 December 2017

issue

3

1 reference

10 December 2017

page(s)

257-262

1 reference

Mortality of hepatitis B positive blood donors in England and Wales

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Hepatitis B in a hospital for the mentally subnormal in southern England

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Prevalence of hepatitis B infection among residents of an institution for the mentally retarded

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Priorities for immunisation against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Seroconversion Rates with Hepatitis B Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Hepatitis B Vaccine in a Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

No increased incidence of AIDS in recipients of hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

Who should be immunised against hepatitis B?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3506%2888%2980068-4

7 January 2021

10.1016/S0033-3506(88)80068-4

Identifiers

DOI

1 reference

10 December 2017

1 reference